✦ LIBER ✦
VANTAGE 014: Vorinostat (V) in Patients With Advanced Malignant Pleural Mesothelioma (MPM) who Have Failed Prior Pemetrexed and Either Cisplatin or Carboplatin Therapy: A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial
✍ Scribed by L.M. Krug; H. Kindler; H. Calvert; C. Manegold; A.S. Tsao; D. Fennell; G.M. Lubiniecki; X. Sun; M. Smith; P. Baas
- Book ID
- 117660597
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 64 KB
- Volume
- 47
- Category
- Article
- ISSN
- 0959-8049
No coin nor oath required. For personal study only.